FDA Untitled Letters
GovPing monitors FDA Untitled Letters for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 4 changes logged to date.
Monday, March 23, 2026
FDA Advisory Letters Notify Firms of Federal Law Violations
The FDA's Center for Veterinary Medicine is posting Untitled Letters on its website to inform the public about firms violating federal law. These letters notify firms of violations that do not meet the threshold for a Warning Letter but still require correction.
FDA Untitled Letters Issued 2011-2018
The FDA has posted a collection of 83 untitled letters issued between 2011 and 2018 by its Center for Food Safety and Applied Nutrition (CFSAN). These letters address violations related to manufacturing controls or labeling that did not meet the threshold for a Warning Letter.
FDA CBER Issues Untitled Letters for Violations
The FDA's Center for Biologics Evaluation and Research (CBER) issues untitled letters to regulated industries for violations that do not meet the threshold for a Warning Letter. These letters address issues found in advertising and promotional labeling, bioresearch monitoring, and internet surveillance.
FDA Untitled Letters to Pharmaceutical Companies
The FDA's CDER Freedom of Information Office has published a list of 34 untitled letters issued to pharmaceutical companies between February 2026 and September 2025. These letters address promotional communications for various prescription drugs, indicating potential violations of FDA regulations regarding drug advertising and promotion.
Get daily alerts for FDA Untitled Letters
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source details
Activity
Browse Categories
Get FDA Untitled Letters alerts
We'll email you when FDA Untitled Letters publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.